Sundrug

The Direx acquisition: a second format (2009)

Key decision·2009· Sundrug — the full company history →

Covering the ground your strength cannot reach, with a different format

The heart of this acquisition lies in filling the space outside the trade area where its own drugstores work best — with a format of a different character. The low-cost store Sundrug had honed in cities and their suburbs is hard to run profitably if simply stretched out into thinly populated country. Rather than fill that blank with stores of its own, Sundrug swallowed whole a company that held a different answer: a discount store carrying goods down to fresh food. Sharing the same foundation of low-cost management, but using two formats according to differences of customer and location — the founding generation’s fixation on the trade area can be seen coming to fruition in the shape of a twin-format business.

That said, while the two-format shape pushes up scale, it also carries the difficulty of running businesses of different character inside one company. A discount store, weighted toward food and fresh produce, earns a thinner gross margin than a drugstore built around medicines and cosmetics, and rising sales do not necessarily lift the profit rate in step. As the industry moved toward trillion-yen combinations like Matsukiyo Cocokara and Welcia-Tsuruha, Sundrug stayed out of the large reorganizations, choosing its own path with two formats and loose alliances. How to keep binding the urban drugstore and the rural discount store together — the choice made in the 2009 acquisition is still being tested today.

Revenue and net margin, FY2004–FY2014

Revenue in ¥ bn (bars) and net margin in % (line), for the years around the decision. Shaded columns are FY2009 onwards — after it was taken.

Source: securities reports

Read the full dossier in Japanese →

The Japanese edition carries the complete record of this decision — the situation that forced it, the options weighed, what actually followed, and the sources behind every claim.

Other key decisions at Sundrug


Yen amounts are converted at the average rate of each figure’s own year — not today’s rate; the revenue chart is shown in yen. Exchange rates & sources — the full ¥/US$ table →


Disclaimer

  • This page is provided for general information only and is not investment advice, nor a recommendation to buy or sell any security.
  • Figures are compiled independently and include our own estimates, approximations and machine-processed data; we make no warranty as to their accuracy or completeness.
  • Sources are primarily each company’s securities reports and other public filings, but errors and omissions may remain.
  • Any use of this information is at the reader’s own risk. Past performance does not indicate future results.
  • Company names, logos and other marks belong to their respective owners.

Data API

Sundrug’s history, financials, executives and shareholders are published as static JSON — no key, plain GET. Full specification →

Method Endpoint Returns
GET /api/companies.json All companies
GET /api/9989/manifest.json Resource index
GET /api/9989/history.json History overview
GET /api/9989/timeline.json Chronology
GET /api/decisions.json All management decisions (index)
GET /api/9989/decisions.json Management decisions (index)
GET /api/9989/decisions/{slug}.json One decision (full dossier)
GET /api/9989/executives.json Executives
GET /api/9989/shareholders.json Major shareholders
GET /api/9989/financials.json Financial statements
GET /api/9989/financials-longterm.json Long-term results
GET /api/9989/segments.json Business segments
GET /api/9989/regions.json Sales by region
GET /api/9989/workforce.json Workforce